>>> US After Hours Summary: TRIL +31% following trial updates, equ

After Hours Summary: TRIL +31% following trial updates, equity investment; WORK -19% following earnings/guidance

After Hours Gainers:

Companies trading higher in after hours in reaction to earnings/guidance: QRVO +5.3%

Companies trading higher in after hours in reaction to news: TRIL +31.2% (provided updated data from TTI-622 and TTI-621 studies; announced equity investment from Pfizer [PFE]), MRNA +4.7% (in reaction to vaccine trial hold for AZN), AGIO +1.1% (appointed Jonathan Biller as CFO)

After Hours Losers:

Companies trading lower in after hours in reaction to earnings/guidance: WORK -18.8%, LULU -5.7%, CASY -4.7%, COUP -4.7%, ABM -2.3%

Companies trading lower in after hours in reaction to news: ATNX -9.1% (announced a public offering of 10.0 mln common shares), AZEK -7.5% (launched secondary public offering of 25.0 mln shares of Class A common stock; announced partial release of IPO lock-up restriction), AZN -6.2% (COVID-19 vaccine trial on hold following suspected serious adverse event, per Stat), VRM -5.3% (commenced public offering of 9.0 mln common shares), QGEN -4.5% (announced launch of rapid portable SARS-CoV-2 antigen detection test), UAA -2.2% (announced $75 mln increase to 2020 restructuring plan)